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Neuroserpin, an axonally secreted serine protease inhibitor
Abstract
We have identified and chromatographically purified an axonally secreted glycoprotein of CNS and
PNS neurons. Several peptides derived from it were microsequenced. Based on these sequences, a
fragment of the corresponding cDNA was amplified and used as a probe to isolate a full length cDNA
from a chicken brain cDNA library. Because the deduced amino acid sequence qualified the protein as a
novel member of the serpin family of serine protease inhibitors, we called it neuroserpin. Analysis of the
primary structural features further characterized neuroserpin as a heparin-independent, functional
inhibitor of a trypsin-like serine protease. In situ hybridization revealed a predominantly neuronal
expression during the late stages of neurogenesis and in the adult brain in regions which exhibit synaptic
plasticity. Thus, neuroserpin might function as an axonally secreted regulator of the local extracellular
proteolysis involved in the reorganization of the synaptic connectivity during development and synapse
plasticity in the adult.
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We have identified and chromatographically purified
an axonally secreted glycoprotein of CNS and PNS
neurons. Several peptides derived from it were micro-
sequenced. Based on these sequences, a fragment of
the corresponding cDNA was amplified and used as a
probe to isolate a full length cDNA from a chicken
brain cDNA library. Because the deduced amino acid
sequence qualified the protein as a novel member of
the serpin family of serine protease inhibitors, we
called it neuroserpin. Analysis of the primary structural
features further characterized neuroserpin as a
heparin-independent, functional inhibitor of a trypsin-
like serine protease. In situ hybridization revealed a
predominantly neuronal expression during the late
stages of neurogenesis and in the adult brain in regions
which exhibit synaptic plasticity. Thus, neuroserpin
might function as an axonally secreted regulator of the
local extracellular proteolysis involved in the reorgan-
ization of the synaptic connectivity during development
and synapse plasticity in the adult.
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developing rat nervous system during the period of axon
outgrowth has been revealed (Sumi et al., 1992; Dent
et al., 1993). Moreover, several pieces of evidence were
presented which indicated that serine proteases, such
as plasminogen activators or thrombin, are involved in
restructuration of the synaptic connectivity during develop-
ment and regeneration. Such processes include synapse
elimination during development (Hantai et al., 1989;
Connold and Vrbova, 1994; Liu et al., 1994) and synaptic
plasticity associated with learning and memory in the
adult (Meiri et al., 1994; Qian et al., 1993).
Here we present the purification, the molecular cloning
and the expression pattern of a glycoprotein that is secreted
from axons of several neuronal populations of both the
PNS and the CNS (Stoeckli et al., 1989). The deduced
primary structure of this novel protein was found to be
homologous to the members of the serine protease inhibi-
tors of the serpin family (Schapira and Patston, 1991).
The expression of this novel serpin is restricted to the
nervous system, unlike other members of the serpin family,
such as protease nexin 1 (PN-1 Baker et al., 1980;
Guenther et al., 1985; Gloor et al., 1986), al-antichymo-
trypsin (AChT; Rayford et al., 1992), plasminogen activ-
ator inhibitor 1 (PAIl; Rao et al., 1993) or antithrombin
III (ATIII; Deschepper et al., 1991), which are expressed
widely outside the nervous system. Based on its structural
characteristics and its expression pattern, we have termed
this protein neuroserpin. The intriguing temporo-spatial
pattern of expression and the fact that it is secreted from
axons implicate neuroserpin as a regulator of proteolytic
events associated with synapse restructuring functions
during neural development, such as the elimination or
segregation of synapses and synaptic plasticity in the adult
nervous system.
Introduction
During the development of the nervous system, neurons
form axons which extend along a prespecified path into
the target area, where they engage in the formation and
the refinement of synaptic connections. These stages
depend critically on the capability of the axonal growth
cones to interact with a variety of structures which
they encounter along their way and at their destination,
including cell surfaces, of neuronal and non-neuronal
origin, and the extracellular matrix. Along their trajectory
and at their target sites, growth cones not only receive
and respond to signals from their local environment,
but also actively modify it by secreted macromolecules
(Sweadner, 1981). In particular, secreted proteases have
been implicated in supporting the growth cone advance-
ment through the tissue. More than a decade ago, it was
demonstrated that plasminogen activators are produced
and axonally secreted by neurons in culture (Krystosek
and Seeds, 1981a,b). Recently, their occurrence in the
Results
Identification of neuroserpin among the axonally
secreted proteins of dorsal root ganglia and
ventral spinal cord neurons
Neuroserpin (then denoted axonin-2) was initially charac-
terized as one of two axonally secreted proteins in cultures
of chicken embryonic dorsal root ganglion (DRG) neurons
using a compartmental cell culture system that provides
separate access to somas and neurites (Ruegg et al., 1989;
Stoeckli et al., 1989). In that study, neuroserpin was
demonstrated to be secreted into the culture medium by
dissociated cultures of several other neuronal populations
of the CNS and the PNS. In order to investigate also a
neuronal population of the CNS with regard to the capa-
bility to secrete neuroserpin from the neurites, we have
cultured ventral spinal cord (vSC) neurons (Sonderegger
et al., 1984) using the same compartmental cell culture
system and metabolically labelled the newly synthesized
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proteins with [35S]methionine. The proteins released from
the neurites into the side compartment were collected and
subjected to two-dimensional SDS-PAGE followed by
fluorography (for a detailed description see Stoeckli et al.,
1989). As demonstrated in Figure 1, the radioactively
labelled proteins of the side compartment medium of the
vSC cultures are distinct from those found with DRG
neurons except for the 55 kDa protein, which we called
neuroserpin, due to the characteristics described below.
Based on the in vitro results presented in the previous
report (Stoeckli et al., 1989) and the in situ hybridization
studies presented here, neuroserpin is a neuronal protein
that is synthesized in and secreted from several neuronal
populations. In at least one neuronal population of each
of the PNS and the CNS, the neuritic release of neuroserpin
has been demonstrated.
Purification and microsequencing of neuroserpin
Quantitative limitations excluded conditioned media of
primary cultures as a source of purification. Ocular vitreous
fluid (VF) from 14-day-old (E14) chicken embryos was
chosen as the source material for the purification of
neuroserpin. Although unfractionated VF did not contain
detectable amounts of neuroserpin (see also Ruegg et al.,
1989), we suspected the presence of small quantities
because neuroserpin was previously found to be released
from retinal neurons in culture (Stoeckli et al., 1989). In
the absence of a functional assay, the fractions of each
purification step were tested for the presence of neuroserpin
by two-dimensional SDS-PAGE followed by silver stain-
ing. The purification procedure, consisting of preparative
isoelectric focusing (IEF), hydrophobic interaction chro-
matography and preparative SDS-PAGE, was devised as
a scale-up of the analytical two-dimensional SDS-PAGE,
taking advantage of the known isoelectric point (IEP) and
molecular mass (Mr) of neuroserpin (Figure 2). With the
procedure detailed in Materials and methods we were able
to purify ~5-10 ,ug neuroserpin from 400 ml VF containing
750 mg protein in total.
An antiserum against the purified neuroserpin was raised
in a rabbit. With this antiserum, the axonally secreted
55 kDa protein of the cultured DRG neurons was specific-
ally precipitated (Figure 3). This confirmed the identity
of the purified protein from VF with the axonally secreted
glycoprotein identified previously in the compartmental
cell culture system.
The purified neuroserpin was subjected to partial amino
acid microsequencing using an automated sequenator. For
the determination of internal sequences, the purified protein
was enzymatically cleaved with the endoproteinases AspN
or trypsin and the generated peptides were isolated by
reversed phase liquid chromatography. Contiguous amino
acid sequences over 24, 6, 9, 6 and 9 amino acids
respectively, were obtained from the amino terminus and
four internal peptides of the purified 55 kDa protein
(Figure 4).
Molecular cloning and primary structure of the
neuroserpin cDNA
The cDNA of neuroserpin was cloned by two independent
approaches. First, nested PCR on embryonic chicken retina
cDNA was carried out using degenerate oligonucleotide
primers corresponding to the amino terminus and two of
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Fig. 1. Characterization of neuroserpin as an axonally secreted protein
of DRG and ventral spinal cord neurons in the compartmental cell
culture system. Dissociated dorsal root ganglion (DRG) neurons and
ventral spinal cord (vSC) neurons respectively, were cultivated in a
compartmental cell culture system (Campenot, 1977). In this system,
the cell culture surface is subdivided into three chambers by a Teflon
divider which is attached to the floor of the culture dish with silicone
grease so that a thin film of medium connects the adjacent
compartments. If dissociated neurons are plated into the centre
compartment, they settle down and remain confined to this area. The
axons, however, can grow within the medium film underneath the
separating barrier and extend into the side compartments (pictograms
at the bottom of each autoradiography). After the neurites had reached
the side compartments, the neuronal proteins were metabolically
labelled by adding [35S]methionine to the medium of the centre
compartment. Secreted proteins in the conditioned media from both
the central and the side compartments, were analysed by two-
dimensional SDS-PAGE and fluorography. The origin of the protein
sample is indicated as a grey shaded area in the pictogram. Note that
neuroserpin (arrow) is secreted into the side compartments (right
panels) from the axons of both DRG neurons (top) and vSC neurons
(bottom).
the internal peptides. A 700 bp fragment was amplified
and subsequently used to screen a chicken embryonic
brain cDNA library (Zuellig et al., 1992). Secondly, the
same library was screened with the rabbit antiserum
against neuroserpin. Several positive clones were identified
with each method and were sequenced. In both groups
one full length cDNA was found. The two clones were
identical except for a different length of the 3' untranslated
region (UTR) due to alternative use of polyadenylation
sites (Figure 4). The sequence contained one long open
reading frame (ORF) of 1230 bp. The nucleotide and the
deduced amino acid sequence of neuroserpin are shown
in Figure 4. In total, the cDNAs span over 1950 and 1510
nucleotides respectively, subdivided in a short 5' UTR, a
1230 bp ORF and a 0.7 kb or 0.25 kb 3' UTR. Polyadenyl-
ation signals (Sheets et al., 1990) are located at positions
1478 and 1920 respectively. The nucleotide sequence
adjacent to the putative start methionine at the amino
terminus of the only long ORF conforms to the consensus
described by Kozak (1987). The amino acid sequence of
the ORF starts with a hydrophobic stretch of 16 amino
acids conforming to the consensus signal sequences (von
Heijne, 1983). The sequence starting with the 17th amino
2945
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Fig. 2. Purification of neuroserpin from vitreous fluid of chicken embryos. Neuroserpin was purified from the ocular vitreous fluid (VF) of 14-day-
old chicken embryos. Fractions of each purification step were tested for the presence of neuroserpin by two-dimensional SDS-PAGE followed by
silver staining. The horizontal bar in the elution profile indicates the fractions selected for the following step. (A) Preparative isoelectric focusing of
VF using the ROTOFOR chamber. Protein concentration (full line) and pH (broken line) of each fraction were determined. (B) Elution profile of the
hydrophobic interaction chromatography using a TSK-Phenyl-5PW column. Elution was achieved with a decreasing gradient of ammonium sulfate
(broken line). (C) Preparative SDS-PAGE using the 230 A HPEC system with a 6% polyacrylamide gel. The electrophoretic system was first
calibrated with molecular weight standards of 29 kDa, 45 kDa and 66 kDa respectively (elution time indicated by arrows). (D) SDS-PAGE analysis
of the fractions of each step that were selected for further processing. Purified neuroserpin after step C appears homogeneous and exhibits a
molecular mass of -55 kDa (lane C, indicated by *).
acid corresponds to the sequence of the amino-terminal
peptide. The four internal peptides of purified neuroserpin
were found in the deduced amino acid sequence, con-
firming the authenticity of the cDNA. The deduced amino
acid sequence of neuroserpin after cleavage of the pre-
sumptive signal peptide adds up to a molecular mass of
45 kDa and an isoelectric point of 4.9. Sequences NHT and
NTS representing potential sites for N-linked glycosylation
are located at positions 157 and 401. Thus, the 10 kDa
difference between the calculated molecular mass and the
molecular weight determined by SDS-PAGE (Figure 2D)
as well as the isoelectric variants seen on two-dimensional
SDS-PAGE (Figures 1 and 3) may be explained by
N-linked glycosylation.
Searches in the GenEMBL and SwissProt databases
identified neuroserpin as a novel member of the serpin
family. With two pairs of nested primers flanking the
putative reactive site loop (Figure 4), we amplified a
corresponding cDNA fragment of -450 bp from a commer-
cial human fetal (17-18 weeks) brain cDNA library
(Stratagene) and from neonatal mouse mRNA respectively.
The deduced amino acid sequences of the human and the
mouse cDNA fragments exhibited a sequence identity of
88% and 87% respectively, with chicken neuroserpin.
Both the human and the murine fragment were distinct
from any of the known mammalian serpins and both had
an amino acid identity with the nearest relative of ~35%.
Sequence comparisons of neuroserpin with other serpins
revealed amino acid sequence identities in the range of
33-42% (Table I). Alignment of the putative reactive site
loop of neuroserpin with inhibitory and non-inhibitory
Fig. 3. Immunoprecipitation of neuroserpin from the supernatant of
cultured DRG neurons by the polyclonal antiserum raised against the
protein purified from vitreous fluid. Total proteins (A) and proteins
precipitated by the polyclonal antiserum against purified neuroserpin
(B) from the conditioned medium from metabolically labelled DRG
neurons were separated by two-dimensional SDS-PAGE and analysed
by fluorography. Neuroserpin is recognized by its characteristic spot
pattern (arrows). (A) Neuroserpin among other proteins produced and
secreted from dissociated cultures of DRG neurons. (B) Neuroserpin
specifically precipitated by the rabbit polyclonal antiserum against
purified neuroserpin from vitreous fluid.
serpins revealed a high degree of similarity to the inhibitory
serpins and a substantially lower resemblance to the non-
inhibitory serpins in the functionally important hinge
region P17-P9 (denoted according to Schechter and Berger,
1967) near the carboxy terminus (Figure SA).
Serpins which are enhanced in their anti-proteolytic
function by heparin (for example PN- 1) have five to seven
basic residues within a short segment in their amino-
terminal moiety forming the so-called heparin-binding
2946
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1
M Y F L G L L S L L V L P S
91 _
TAAAGCCTTCAAGACCAATTTTCCTGATGAAACTATTGCTGAGCTTrCTGTGAATGTTTACAATCAGCTACGAGCTGCAAGAGAAGATGA
K A F K T N F P D E T I A E L S V N V Y N O L R A A R E D E
181
GAATATTCTMCTGTcCTCTGAGCATlGCAATAGCCATGGGAAnTGATAGAGCTrGGAGCCCAT GGAACCACTTTGAAAGAAATrCGACA
N I L F C P L S I A I A M G M I E L G A H G T T L K E I R H
271
TTCATTGGGTTTTrGACAGCTTAAAAAATGGTGAAGAGCATTACcI"ITGAAGGACCri"TGATATGGCAACrACGGAAGAAAGTCATTA
S L G F D S L K N G E E F T F L K D L S D M A T T E E S H Y
361
TGIrAAATATGGCAACTCTCTCTATGTTCAGAAT1AGATA A AGT G AAAATACTTTAAAGC
V L N M A N S L Y V Q N G F H V S E K F L Q L V K K Y F K A
451
TGAAGTAGAGAACATAGATTTCAGCCAGAGTGCAGCTGTAGCTACCCACATCAATAAGTGGGTAGAGAATCATACAAACAATATGATCAA
E V E N I D F S Q S A A V A T H I N K W V E N H T N N M I K
541
AGATTGTGT TCAAGAGACTTCAGTG_TAACTCACTTGGTTCTCATCAATGCAATCTACITIAAAGGCAAETGAAATCACAGTT
D F V S S R D F S A L T H L V L I N A I Y F K G N W K S Q F
631 _ _ _ _ _ _ _
CAGACCTGAAAATACAAGAACTPr=TTT CACTAAGGATGATGAAACTGAAGTGCAGATTCCAATGATGTACCAGCAAGGAGAGTTTTA
R P E N T R T F S F T K D D E T E V Q I P M M Y Q Q G E F Y
721
TTATIGAGAGTTCAGTGATGGCTCTAATAAGCAGGTGGTATCTACCAAGTTCTAGAAATACCATATGAAGGAGATGAAATTAGTATGAT
Y G E F S D G S N E A G G I Y Q V L E I P Y E G D E I S M M
GATTGTTCITTCCAGACAGGAAGTTCCGCTGGTCACATTGGAGCCACTTGTTAAAGCCTCATTGATTAATGAGTGGGCTAACTCTGTAAA
I V L S R Q E V P L V T L E P L V K A S L I N E W A N S V K
901
AAAGCAAAAAGTTGAAGTATATFICAAGGTTCACAGTAGAGCAAGAAA¶GATCTYAAAGATGTATTGAAAGGTCTTGGAATTACAGA
K Q K V E V Y L P R F T V E Q E I D L K D V L K G L G I T E
AGTGTTCAGCCGTAGTGCTGACCTCACTGCCATTCTGATAACAAAGAACTrrACCTTGCAAAGGCATTrCATAAGGCTTTCCTAGAAGT
V F S R S A D L T A M S D N K E L Y L A K A F H K A F L E V
1081
__ _ _ _ _
TAATGAGGAAGGATCAGAAGCTGCTGCGCCTCAGGAATGATTGCCATrAGCAGAATGGCAGTACTGTATCCTCAAGTTATAGTrGATCA
N E E G S E A A A A S G M I A I S RWM A V L Y P Q V I V D H
1171 _ _ _ _ _ _ _
TCCTTTCTTCTTCCTGGTCAGAAACAGAAGAACAGGCACTGTGTTATTCATGGGGAGGGTAATGCACCCTGAAGCAATGAATACAAGIGG
P F F F L V R N R R T G T V L F M G R V M H P E A M * T S G
1261
CCATGACTTTGAAGAGCTTTAACTACTGCCAGCTACC _TCAATATA'AAGGT
H D F E E L
1351
GTGTTCCTCCCCCCAAGATATT&GAAAATGCT¶AGATCTAITGTCAAGTGAGTTTCCAGAGGAAAAGTTCACAGTATTAAAATAAT
1441
GGTTCIG?rA11GTGA¶GCTGTGTCCTTAAA&TAAAATTGTGTACATGTCAACAACTGTTTCTTGTTCTAGTGAATTGTGAAG
1531
1621
GAGTAATCAAATGACAAACCATTATITATAGTTGAACICA1I TAATAGTAAACAGACTGCAGCATGCTGTCT
1711
CTATCTAGAGAACTGTGGTAGACTGTGTAAACTCCAACGTGIGGTTCTAAAATGCTG
1801
CTGTTATGAATGCTCCTGCATGCAACTCCGCGATTCACCTTCCGTAAGTGTTGATACTAATAAAATTGATCGCATGAGTATFIrAAGCT
1891
AGTCAGTGTAGAATAGCTGYGGATATCCAAATTAAAATAGTTGACACTCAAAAAAAAAAAA
Fig. 4. The cDNA of neuroserpin. Full length cDNA of neuroserpin cloned from a chicken brain E14 cDNA library. A long and a short neuroserpin
cDNA with an identical ORF of 410 amino acids were found. They differed only in length at the 3' end due to alternative usage of polyadenylation
signals (bold). Sequenced peptides are underlined and the amino-terminal signal sequence is printed in italics. The primers for the initial PCR-
amplification are indicated by solid arrows, the primers flanking the reactive site loop by broken horizontal arrows, possible sites for N-glycosylation
are marked by asterisks (*) and the putative reactive site between R362 and M363 is marked by the scissors pictogram. The GenBank accession
number for the neuroserpin sequence is Z71930.
exosite (Evans et al., 1993). When presented as a helical
wheel (Figure 5B) the positively charged residues cluster
in close proximity. The corresponding segment of neuro-
serpin (G84-E1I1) shows a concentration of negative
charges on the surface of the corresponding helix. This
difference indicates that the anti-proteolytic activity of
neuroserpin is heparin-independent.
Expression of neuroserpin mRNA in vivo
The in vivo distribution of the neuroserpin mRNA was
investigated by Northern blot analysis and in situ hybrid-
ization. Blot analysis confirmed the existence of two
neuroserpin mRNAs of 1.7 and 2.2 kb respectively. High
levels of neuroserpin mRNA were found in embryonic
(E14) retina, brain, cerebellum and spinal cord. No tran-
scripts were detected in embryonic lung, liver, kidney,
heart or skeletal muscle. In the adult chicken, a high
concentration of neuroserpin mRNA was found in the
brain. Again, no transcripts were detected in non-neuronal
tissue such as liver, kidney, heart or skeletal muscle,
except for a small quantity of the 1.7 kb, but not of the
2.2 kb, transcript in the adult lung (Figure 6A).
In situ hybridization revealed strong cellular signals
indicative of neuroserpin mRNA in both the PNS and the
2947
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Table I. Percentage similarity of serpins
PN-1 (h) PN- I (r) PAI I (h) PAI I (m) LEI(h) ATIII(h) a I AT(h) OA(c)
NS(c) 42 42 39 39 39 38 33 37
PN- I (h) 88 45 43 38 36 28 35
PN- I (r) 46 44 38 36 29 36
PAI I (h) 82 35 34 34 32
PAI I (m) 36 34 33 32
LEI(h) 47 34 47
ATIII(h) 33 38
a AT(h) 35
Seven different serpins and two species homologues of the same serpin were aligned in pairs and the percentage of identical amino acids is
indicated. Neuroserpin (NS) was compared with protease nexin 1 (PN-1), plasminogen activator inhibitor 1 (PAI1), leucocyte elastase inhibitor (LEI),
antithrombin III (ATIII), axl-anti-protease (cxlAT) and the non-inhibitory ovalbumin (OA). The comparisons between neuroserpin and other serpins
are printed in bold. The similarity of species homologues is printed in italics. Species are indicated in parentheses (c, chicken; h, human; r, rat;
m, mouse).
CNS. The neuroserpin-expressing cells of the CNS were
exclusively located in the grey matter and the majority had
large cell somas. During neural development, neuroserpin
expression was found in most areas of the nervous system,
whereas in the adult, neuroserpin mRNA was restricted
to relatively few areas. An overview of the expression of
neuroserpin in neural tissue at different stages is shown
in Figure 6.
Neuroserpin was first detected at stage 23 (staged
according to Hamburger and Hamilton, 1951; correspond-
ing to embryonic day four) in the floor plate and the
intermediate zone of the spinal cord (Figure 6B). The
expression in the floor plate was found continuously
diminished with time and had disappeared at stage 38
whereas a strong signal was still detected in the inter-
mediate zone of the spinal cord at stage 38. At stage 28,
medial motoneuron pools started to express neuroserpin
mRNA. At stage 33, neuroserpin mRNA appeared in a
lateral pool of large motoneurons (marked by asterisks).
A few scattered neurons of the ventral horn exhibited
strong neuroserpin expression in spinal cord sections of
adult chickens.
In the embryonic retina (Figure 6C), the first signals
were detectable at stage 36 in the ganglion cell layer
and the inner nuclear layer. The strongest expression of
neuroserpin mRNA was from stage 43 to 46 (hatching)
and transcripts remained detectable until adulthood in the
ganglion cell layer and the inner nuclear layer. In contrast,
no cells of the plexiform layers or among the photorecep-
tors were neuroserpin-positive throughout the tested time
frame.
In the cerebellum (Figure 6D), a strong signal was seen
in Purkinje cells between stages 38 and 43, whereas only
a few scattered cells in the granule cell layer expressed
neuroserpin at these stages. No cells in the molecular
layer were neuroserpin-positive at any time. In the optic
tectum, the first neuroserpin transcripts appeared at stage
38 (not shown) in the stratum griseum et fibrosum super-
ficiale (SGFS, according to LaVail and Cowan, 1971), the
stratum griseum centrale (SGC) and the stratum griseum
periventriculare (SGP), but not in the fibre layers. The
strongest signals were detected around stage 43 (Figure
6E) in the large multipolar neurons of the SGC and most
of the pyramidal and multipolar cells of laminae g, h and
i in the SGFS. Sustained expression was registered in the
adult animal in a few isolated neurons of the laminae g
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Fig. 5. Alignment of reactive site loops and the heparin-binding
exosite of different serpins. (A) The putative reactive site loop of
neuroserpin (NS) was compared with reactive site loops of the
inhibitory serpins protease nexin 1 (PN-1), plasminogen activator
inhibitor I (PAII), antithrombin III (ATIII), cxl-anti-protease (alAT)
and with the non-inhibitory serpin ovalbumin (OA). Sequences were
aligned by the program GAP of GCG (according to Needleman and
Wunsch, 1970). Identical amino acids are highlighted in black and
conservative changes in grey boxes. The putative reactive site amino
acids are outlined. Nomenclature of P17 to PI and PI' is according to
Schechter and Berger (1967); Species are indicated in parentheses
(c, chicken; h, human). (B) A helical wheel comparison of the
heparin-binding exosite of PN-1 and the corresponding sequence of
neuroserpin shows the markedly different distribution of acidic (grey
shaded) and basic (black outlined) amino acids in the putative surface-
exposed areas of helix D.
through i in the SGFS (data not shown). A sagital section
through the adult brain (Figure 6F) revealed neuroserpin
expression in neurons throughout the hyperstriatum
accessorium, the neostriatum and the hippocampus, as
well as in particular thalamic nuclei (Kuenzel and
Masson, 1988).
Discussion
We purified, microsequenced and cloned neuroserpin,
a novel serine protease inhibitor of the serpin family.
Neuroserpin is synthesized by neurons of both the CNS
and the PNS and it is secreted from axons. Neuroserpin
expression starts during the late stages of development
and persists in adulthood. The axonal secretion and the
temporo-spatial pattern of expression implicate neuro-
serpin as a local modulator of extracellular proteolytic
2948
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Fig. 6. Expression of neuroserpin mRNA during development and in the adult. (A) Northern blot analysis of neuroserpin mRNA. 7.5 pg total RNA
from embryonic (E14) and adult chicken retina (Re), brain (Br), cerebellum (Ce), spinal cord (Sc), lung (Lu), liver (Li), kidney (Ki), heart (Hm) and
skeletal muscle (Sm) were electrophoretically separated, transferred to a PVDF membrane and analysed with DIG-labelled neuroserpin antisense
cRNA. Approximately equal loading and integrity of the RNA is demonstrated by hybridization with a glyceraldehyde-3-phosphate dehydrogenase
cRNA (GAP-DH). (B-F) In situ hybridization of neuronal tissue with DIG-labelled and partially hydrolysed neuroserpin antisense cRNA: (B) Spinal
cord and DRGs (stage 23 to adult). Neuroserpin mRNA appears first at stage 23 in the floor plate and in a lateral cell population located in the
intermediate zone of the spinal cord. Note that no signal is found in motoneurons at this stage (circles). The expression of neuroserpin in the floor
plate disappears completely at stage 38. After stage 28 neuroserpin mRNA is found in more and more cells of the ventral spinal cord including
different pools of motoneurons. Highest levels of neuroserpin mRNA are detected during stages 33-36, when motoneurons form functional synapses
with their target muscles. For instance, an asterisk indicates the staining of neuroserpin mRNA in a lateral motoneuron pool with highest intensities
during stages 33-36. The signal decreases afterwards (stage 38). However, some lateral motoneurons still express neuroserpin in the adult chicken.
(Bars: 100 pm in the upper and 500 pm in the lower panel; the broken line indicates the boundary between grey and white matter in the adult spinal
cord). (C) Retina (stage 36 to adult; GCL, ganglion cell layer; INL, inner nuclear layer; PE, pigment epithelium). (D) The cerebellum (stage 40;
M, molecular layer; G, granule cell layer; P, Purkinje cells) and (E) the optic tectum (stage 43; SGFS, stratum griseum et fibrosum superficiale;
SGC, stratum griseum centrale). (F) A sagital section through an adult chicken brain (Ce, cerebellum; Hc, hippocampus; HA, hyperstriatum
accessorium; N, neostriatum; Th, thalamus).
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processes occurring at the synapse during neural develop-
ment and in the adult.
Neuroserpin is a presumptive inhibitor of
trypsin-like proteases
The primary structural features qualified neuroserpin as a
member of the serpin family of serine protease inhibitors.
The serpins are a large family of structurally related
proteins which are divided into two subclasses, the serpins
with and without anti-proteolytic activity. Despite a high
similarity of their spatial structure, different serpins exhibit
only ~30-50% amino acid identity, whereas species homo-
logues of the same serpin are 80-90% identical in primary
structure (Table I). Because no serpin with a sequence
identity higher than 42% (PN-1) is known, but the partial
amino acid sequences of the human and the mouse
neuroserpin show an identity of 88% and 87% respectively,
to the corresponding region of the chicken cDNA, it can
be ruled out that neuroserpin is the chicken homologue
of any of the presently known serpins. This conclusion is
supported by the axonal secretion and the predominantly
neuronal expression of neuroserpin, features that have not
been reported about the presently known serpins.
The great majority of the serpins act as inhibitors of
serine proteases, but some members of the family, e.g.
ovalbumin, thyroxine-binding globulin, corticosteroid-
binding globulin and angiotensinogen, have no anti-proteo-
lytic activity. Ovalbumin is the best characterized of the
non-inhibitory serpins (Gettins, 1989; Stein et al., 1990).
It differs substantially from inhibitory serpins within the
region corresponding to the hinge of the reactive site loop
(P17 to P9; Figure 5A), where its long-chain and bulky
amino acid residues may restrict the mobility required
for inhibitory action (Wright et al., 1990). In contrast,
neuroserpin bears the typical traits common to the family
members with protease inhibitory function within its most
carboxy-terminal region where the reactive site is located.
In particular, it exhibits a glutamic acid (E346) in position
P17, a small uncharged amino acid (G 348) at P15 and four
short-chain amino acids (A351-A354) at P12-P9 required
for the large conformational changes that anti-proteolytic
serpins must undergo during activation (Huber and Carrell,
1989; Gettins et al., 1993; Hopkins et al., 1993; Schulze
et al., 1994).
The type of the target protease is thought to be specified
by the positions PI and PI' of the reactive site loop
(Lawrence et al., 1990; Nick et al., 1990; Sherman et al.,
1992). With an arginine and a methionine respectively, at
these positions, neuroserpin is most likely targeted against
trypsin-like proteases. Neuroserpin does not comprise a
sequence rich in basic amino acids in the amino-terminal
moiety. Thus, it appears to belong to the heparin-independ-
ent group of serpins (Evans et al., 1993). Whereas heparin-
dependent serpins, such as ATIII (Blackburn et al., 1984),
heparin cofactor (HCOF; Blinder and Tollefsen, 1990) or
PN-1 (Stone et al., 1994), bear five to seven basic amino
acids at conserved positions in their heparin-binding
exosite, neuroserpin carries six acidic residues, but only
one lysine at the corresponding positions in this 18-amino-
acid stretch (G84-E101; see Figure SB).
Antiproteolytic serpins have been implicated in a variety
of physiological functions, ranging from a rather general
protection against proteolytic attack to subtle regulatory
functions within intricate proteolytic cascades (Schulze
et al., 1994). Convincing evidence has been accumulated
over the past years that extracellular serine proteases play
key roles in development, plasticity and regeneration of the
vertebrate nervous system. Likewise, protease inhibitors of
the serpin family, such as AChT (Rayford et al., 1992),
PAIl (Rao et al., 1993), or-most prominently-PN- I
(Guenther et al., 1985), are found in the developing
nervous system and have recently been shown to be
involved in developmental processes such as neurite
outgrowth (Gloor et al., 1986) and synapse elimination
(Liu et al., 1994). Serpin functions in the adult nervous
system include regeneration (Meier et al., 1989) and LTP
(D.Monard, personal communication).
Neuroserpin is secreted from axons of PNS and
CNS neurons
Axonal secretion of neuroserpin was first shown with
DRG neurons cultured in a compartmental cell culture
system (Stoeckli et al., 1989). Using the same approach,
we demonstrated here that neuroserpin is also released
from the axons of cultured neurons of the ventral spinal
cord, presumably motoneurons. Thus, axonal release of
neuroserpin has been observed with one type of neuron
of each of the PNS and the CNS. Without a detailed
investigation of the site of release, neuroserpin has also
been found in the supernatant of a variety of dissociated
cultures of PNS and CNS neurons of different origin,
including ciliary ganglion, superior cervical ganglion,
retina and dorsal spinal cord, but not of non-neuronal
cells, such as peripheral glia, central glia, fibroblasts, heart
muscle, skeletal muscle or liver cells (Stoeckli et al.,
1989). Neuroserpin is also released and accumulates in
the extracellular fluids in vivo, as we have demonstrated
by the analysis of the different chromatographic fractions
of VF in the process of protein purification. Based on
these observations, we consider as warranted the general-
ization that neuroserpin is a secretory protein that accumu-
lates in the extracellular fluid and that axons are a preferred
site of release.
Neuroserpin is the first serpin which is predominantly
produced by neurons and which has been demonstrated
to be axonally secreted. The latter fact is of special
importance since it opens the possibility of a locally
restricted release upon neuronal stimulation, which appears
to be a prerequisite for a molecule supposed to be involved
in the refinement of synaptic connectivity (Constantine-
Paton et al., 1990; Udin and Fawcett, 1988; for a review
see Goodman and Shatz, 1993). Recent experiments on the
neuromuscular junction have demonstrated that activity-
dependent synapse elimination could indeed be prevented
both in vitro and in vivo by addition of the serine protease
inhibitors PN- 1 (Liu et al., 1994) or leupeptin (Connold and
Vrbova, 1994). Intriguingly, spinal motoneurons strongly
express neuroserpin mRNA during the period critical for
developmental synapse elimination.
Neuroserpin is expressed in neurons during the
late stages of neural development and in the adult
The temporo-spatial patterns of neuroserpin expression
suggests that neuroserpin is involved in the regulation of
extracellular proteolytic events underlying diverse
developmental processes. Neuroserpin expression in the
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floor plate of the spinal cord coincides well with the
crossing of the commissural axons in order to join the
contralateral longitudinal tract (Oppenheim et al., 1988;
Stoeckli and Landmesser, 1995). Thus, floor plate neuro-
serpin might be involved in the regulation of axonal
pathway decisions at this location. In the defined neuronal
populations investigated in this study, the first transcripts
appear after the period of axon growth into the target
area. For example the spinal motoneurons first express
neuroserpin mRNA at stage 28, when they have already
extended their axons to the target region and have begun
to form synapses. In retinal ganglion cells, neuroserpin
expression starts at stage 36 and peaks around hatching
(stage 43 to P5). At stage 36, retinal projections have
already reached their destination in the optic tectum (Mey
and Thanos, 1992) and have begun to form synapses with
their target cells. These observations during development
implicate neuroserpin as a regulator for synaptogenesis and
the subsequent remodelling processes including synapse
elimination rather than neurite outgrowth.
The onset of neuroserpin expression after the axons
have reached the target area speaks against a role of
neuroserpin as a regulator of erase, a trypsin-like protease
that has recently been demonstrated to be expressed by
certain cells and to regulate the outgrowth of neurites by
inducing growth cone collapse upon encounter (Baird and
Raper, 1995). However, a discrepancy in the expression
of proteins in vivo and in cultured cells taken at the same
developmental stage is not an uncommon observation and
thus, experimental testing will be necessary to address
this issue.
The most prominent expression of neuroserpin mRNA
in the adult chicken is found in the hyperstriatum acces-
sorium, the neostriatum and the hippocampus. This is
intriguing since a subtle balance between proteolytic
and anti-proteolytic activity seems to be required for
appropriate synaptic function in plastic regions of the
adult brain and consequently in processes of learning and
memory. Transgenic mice with an enhanced proteolytic
activity in the cortex and hippocampus due to overexpres-
sion of urokinase plasminogen activator have been found
to exhibit impaired spatial, olfactory and taste-aversion
learning (Meiri et al., 1994). In line with these observations
are recent results with PN- 1. An elimination of PN-1 by
homologous recombination leads to reduced LTP, whereas
PN-1 overexpression results in enhanced LTP of hippo-
campal neurons.
Conclusion
Neuroserpin is a novel serine protease inhibitor with
predominantly neuronal origin which is secreted from the
axons of both PNS and CNS neurons. In the developing
nervous system it is expressed predominantly during the
formation and reorganization of synapses; in the adult
CNS it is found in areas in which the synaptic changes
associated with learning and memory are thought to occur.
These characteristics implicate neuroserpin as a regulator
of the subtle balance between proteolytic and anti-proteo-
lytic activities at the synapse, which is thought to be
required for an orderly execution of developmental func-
tions such as the formation or reorganization of synaptic
connections, as well as for synaptic plasticity in the adult
nervous system.
Materials and methods
Cell culture
White Leghorn chicken embryos were used throughout this study. Dorsal
root ganglia neurons and ventral spinal cord neurons were dissected
from 10- or 6-day-old chicken embryos respectively, and cultured as
described by Sonderegger et al. (1985). To show axonal secretion, the
compartmental cell culture system originally devised by Campenot
(1977, 1979) was used. Neurons were cultured 4-5 days prior to
metabolic labelling.
Metabolic labelling
Selective labelling of newly synthesized proteins was carried out essen-
tially as described previously (Sonderegger et al., 1983, 1984, 1985).
However, the protein content of the medium was reduced to a minimum
by omitting horse serum during labelling. The labelling medium consisted
of methionine-free growth medium substituted with 0.1-1 mCi/ml
[35S]methionine (1000 Ci/mMol, NEN) and 15 ,uM unlabelled methio-
nine. Incubation time was 40-48 h.
Electrophoretic procedures
SDS-PAGE was carried out according to Laemmli (1970) and two-
dimensional SDS-PAGE was according to O'Farrell (1975) as modified
by Sonderegger et al. (1985). For fluorography, the Phosphorlmager
(Molecular Dynamics) was used. Silver staining was performed according
to the procedure of Switzer et al. (1979) as modified by Oakley et al.
(1980). As molecular weight markers for gels processed by fluorography,
[14C]methylated forms of carbonic anhydrase (29 kDa), ovalbumin
(45 kDa), BSA (66 kDa), phosphorylase (97 kDa) and myosin (200 kDa,
all NEN) were used. For silver stained gels, we used carbonic anhydrase
(29 kDa), ovalbumin (45 kDa), BSA (66 kDa), phosphorylase (97 kDa),
3-galactosidase (116 kDa) and myosin (200 kDa, all from Sigma).
Chromatographic procedures
Vitreous fluid of white Leghorn chicken embryos was prepared as
described elsewhere (Ruegg et al., 1989). For IEF it was dialysed against
water and 2% Ampholines (BioLyte 3-10, Bio-Rad) were added.
Preparative IEF was carried out using the ROTOFOR system (Bio-Rad)
according to the manufacturer's instructions. The pH of each fraction
was determined and fractions with pH 4.8-5.0 were immediately buffered
with 50 mM Tris-HCl to pH 7.25 and stored frozen until further use.
For hydrophobic interaction chromatography, ammonium sulfate was
added to the selected IEF fractions to a final concentration of 1.2 M
prior to loading to the column (TSK Phenyl-5PW, 7.5X75 mm, Bio-
Rad) which was equilibrated with loading buffer (50 mM Tris-HCI,
1.2 M ammonium sulfate, pH 7.25). Bound proteins were eluted by a
linear gradient of decreasing concentration of ammonium sulfate (1.2-
0 M) in 50 mM Tris-HCI, pH 7.25. Fractions from 0.55-0.45 M
ammonium sulfate were stored frozen until further use.
For preparative SDS-PAGE, samples from the hydrophobic interaction
chromatography were precipitated according to Wessel and Fluegge
(1984), redissolved by boiling in sample buffer (3% SDS, 10% glycerol,
62.5 mM Tris-HCI, 0.2% -mercaptoethanol, pH 6.8) and applied to a
2.5x100 mm 6% polyacrylamide gel on a 230 A preparative electro-
phoresis system (HPEC, Applied Biosystems). Electrophoresis was
carried out according to the manufacturer's instructions and the proteins
were eluted with 25 mM Tris-HCI, pH 8.3 in fractions of 50 1l.
Generation of a polyclonal antiserum and
immunoprecipitation
Rabbit antibodies against neuroserpin were raised by intramuscular
injection of 5-10 gg of purified neuroserpin in complete Freund's
adjuvant followed by a booster injection in incomplete Freund's adjuvant
2 months later. The antiserum against neuroserpin obtained 1 week after
the booster injection was specific for neuroserpin in conditioned medium
of cultured DRG neurons, as demonstrated by immunoprecipitation
under native conditions carried out as described elsewhere (Ruegg et al.,
1989). Briefly, cultures of dissociated DRG neurons were metabolically
labelled (Stoeckli et al., 1989), the conditioned medium was adjusted to
precipitation conditions, 10% vitreous fluid was added as a carrier and
the solution was cleared by centrifugation. The radiolabelled neuroserpin
was incubated with 1/50 (v/v) rabbit antiserum for 12 h at RT and,
subsequently, for 2 h at RT with 1/50 of a suspension of glutaraldehyde-
fixed Staphvlococcus aureus in PBS (1 vol/9 vol). Bound antigen-
antibody complexes were released by boiling in 2% SDS/5% ,B-mercapto-
ethanol followed by centrifugation. Proteins of the supernatant were
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precipitated (Wessel and Fluegge, 1984) and processed for two-dimen-
sional SDS-PAGE.
Protein sequence analysis
For the determination of the amino-terminal amino acid sequence of
neuroserpin, 10-20 pmol purified protein was directly blotted onto a
PVDF-membrane (ProSpin, Applied Biosystems). To obtain internal
sequences, enzymatic digestions of neuroserpin were carried out using
endoproteinase Asp-N and trypsin respectively. 1/10 (w/w) of the
appropriate endoproteinase (both sequence grade, Boehringer) was added
to 100-200 pmol neuroserpin in 25 mM Tris-HCI, pH 8.3 and incubated
for 5 h (Asp-N) or 12 h (trypsin) at 37°C. The digestion was stopped
by adding 200 jg/ml DTT and incubating for 1 h at RT under argon;
TFA was added to a final pH of 2. The peptides were separated on a
SMART-System (Pharmacia) equipped with a lRPC C2/C18 reversed
phase column and a 100 RI DEAE-precolumn (Q-Sepharose fast flow,
Pharmacia; see Kawasaki and Suzuki, 1990) using a linear gradient from
0-80% acetonitril in 0.1% TFA. Peptide sequence analysis of the blotted
protein or the eluted peptides was carried out on a 477 A protein
sequencer on-line with a 120 A HPLC detector (both Applied Biosystems)
using standard chemistry.
Cloning and sequencing of the neuroserpin cDNA
Total RNA was prepared from chicken embryonic (E14) retina and
neonatal mouse brain by the method of Han et al. ( 1987) and oligo(dT)-
primed cDNA was produced using SuperScript RNase H- reverse
transcriptase (Gibco) according to the distributor's instructions. As a
template for the human neuroserpin fragment, lambda DNA was prepared
from a human fetal (17-18 weeks) brain cDNA library (Stratagene)
according to Friedman et al. (1988). One sense and two antisense primers
corresponding to the amino terminus and two of the internal peptides
and four primers flanking the reactive site loop and matching the chicken
cDNA sequence were synthesized (Microsynth) with inosine at the
wobble positions and restriction sites for EcoRI, XbaI or BamHI
respectively, at the 5'-end. (sense primer: 5'-GGAATTCAAIACIAA-
ITTICCIGATGAAAC-3'; antisense primers: 5'-GGAATTCACIATC-
ATIGAIACIATITCATC-3' and 5'-GCTCTAGAAIACITCIGTIATICC-
NAG-3'; flanking sense primers: 5'-GCIATITA(C/T)TT(C/T)AA(A/G)-
GGIAA(T/C)TGGAA-3' and 5'-GGGGGATCCGA(A/G)ACIGA(A/G)-
GTICA(A/G)ATICCIATGATG-3'; flanking antisense primers: 5'-CCC-
AT(A/G)AAIA(A/G)IACIGTICCNGT-3' and 5'-GGGGGATCCGG(A/
G)TG(A/G)TCIACIATIAC(C/T)TGNGG-3').
Nested PCR was performed using ampliTaq DNA polymerase (Perkin
Elmer) according to the supplier's recommendations. The identity of the
amplified fragment was verified by the 15 amino acids following the
amino-terminal sequence used for the sense primer. The 700 bp fragment
was subcloned in Bluescript SK(-) plasmid DNA (Stratagene).
About 106 plaques of a XZAPII cDNA library of embryonic chicken
brain (Zuellig et al., 1992) were screened (i) by hybridization with the
radiolabelled PCR fragment under standard high stringency conditions
(Sambrook et al., 1989) or (ii) with the rabbit polyclonal antiserum
against purified neuroserpin as primary and peroxidase-conjugated anti-
rabbit IgG (Bio Science) as secondary antibody. Five positive clones
were found by the immunoscreening and 20 positive clones resulted from
the hybridization screen. They were subjected to further characterization.
Bluescript plasmids containing the putative neuroserpin inserts were
excised in vivo from XZAPII phagemids and digested with EcoRI
endonuclease. Of each screen, the representative with the longest insert
was sequenced using the dideoxy-chain-termination method (Sanger
et al., 1977) with Sequenase 2.0 (USB). For the sequence analysis we
used GCG (Version 7, Unix, Silicon Graphics Inc.).
Northern blot analysis
Total RNA for Northern blots was prepared according to Chomczynski
and Sacchi (1987). DIG-labelled riboprobes of neuroserpin and glycer-
aldehyde-3-phosphate dehydrogenase (GAP-DH) were synthesized using
the DIG RNA labelling kit (Boehringer) according to the supplier's
reccommendations. RNA electrophoresis, transfer to PVDF membranes
(Pall), hybridization and detection by alkaline phosphatase-conjugated
anti-DIG Fab and CDP-Star (both Boehringer) were performed according
to Sambrook et al. (1989) and Boehringer's recommendations.
In situ hybridization
In situ hybridization was carried out essentially as described by Schaeren-
Wiemers and Gerfin-Moser (1993). Briefly, 20 gm sections of chicken
embryos were mounted on poly-L-lysine coated coverslips and shortly
air-dried. DIG labelled sense and antisense cRNA probes corresponding
to the full length cDNA were prepared from neuroserpin cDNA in
pBluescript using the DIG labelling kit (Boehringer) in combination
with T3 and T7 polymerase respectively. Fragments of 200-300 bp of the
cRNA were obtained by alkaline hydrolysis and used at a concentration of
200 ng/ml. Twenty gm sections on poly-L-lysine coated coverslips were
hybridized at 52°C and washed in graded concentrations of SSC with a
high stringency step of 0.2x SSC at 53°C. Immunological detection
of DIG-labelled hybrids was performed using alkaline phosphatase-
conjugated anti-DIG Fab and NBT/BCIP (all Boehringer). The colour
reaction was carried out 12-24 h at room temperature in the dark.
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